Neurodegeneration News and Research

RSS

Neurodegeneration is the umbrella term for the progressive loss of structure or function of neurons, including death of neurons.

Quanterix announces recipients of annual Accelerator Grant Program

Quanterix Corporation, a company digitizing biomarker analysis to advance the science of precision health, today announced Shelli Kesler, Ph.

From Quanterix 3 Oct 2019

Multiple sclerosis genomic map implicates immune cells in disease susceptibility

The International Multiple Sclerosis Genetic Consortium reports the results of its latest study, "Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility", in the journal Science today: the highly productive collaborative group presents a new milestone in its efforts to understand the genetic basis of multiple sclerosis.

26 Sep 2019

Researchers develop superior method to track Alzheimer’s pathology in single neuronal cells

University of Warwick researchers have developed a superior method to describe the very earliest effects that Alzheimer's Disease proteins have on the properties of brain cells.

26 Sep 2019

Chan Zuckerberg Initiative supports a patient-led movement to cure ALS

The Chan Zuckerberg Initiative today announced $453,000 in funding for I AM ALS, a patient-led organization dedicated to raising awareness of Amyotrophic lateral sclerosis and empowering patients to lead the search for a cure.

25 Sep 2019

Promising new target regulating mitochondria during stress identified

Like an emergency response team that is called into action to save lives, stress response proteins in the heart are activated during a heart attack to help prevent cell death.

19 Sep 2019

Quanterix Serum Nf-L assay powers key trial and study results presented at ECTRIMS 2019

Quanterix, announce that its Simoa technology and Nf-L assays were used in many of the groundbreaking research and treatment developments.

From Quanterix 18 Sep 2019

Researchers identify changes in retinal layers of patients with mild Alzheimer's disease

Researchers at the Complutense University of Madrid have identified changes in retinal layer thickness, inflammation or thinning in patients with mild Alzheimer's disease, confirming that the retina is one of the most important biomarkers for early diagnosis of the disease.

13 Sep 2019

Genetic engineering could open possibilities for patients with Parkinson’s disease

People with Parkinson’s disease experience loss of dopamine-producing brain cells, leading to tremors, rigidity, bradykinesia, and postural instability, the primary symptoms of the disease.

11 Sep 2019

Lilly launches new report highlighting challenges and opportunities of health care revolution

Eli Lilly and Company today calls on industry, academia and the NHS to do more to foster collaboration to ensure the UK maintains its global leadership position at the forefront of medicines research and discovery.

9 Sep 2019

Apathy can be used as biomarker of Huntington's disease progression

Researchers from the brain cognition and plasticity group of the Bellvitge Biomedical Research Institute and the Neuroscience Institute of the University of Barcelona have led an innovative study that identifies modifications in the connectivity of cerebral white matter associated with the heterogeneous nature of apathy in Huntington's disease, making it possible to use this syndrome as a biomarker of disease progression.

6 Sep 2019

Scientists visualize protein tangles linked with dementia in patients’ brains after single head injury

Scientists have visualized for the first time protein 'tangles' associated with dementia in the brains of patients who have suffered a single head injury.

5 Sep 2019

Simple urine analysis can be used to quickly identify brain trauma and expedite treatment

A traumatic brain injury is often easily suspected and can be confirmed and treated if necessary following an injury using a blood analysis, but scientists are reporting that even one mild blast to the brain can cause very subtle but permanent damage as well.

5 Sep 2019

New insight and target for Alzheimer’s disease

The body is designed to fix anything that is out of balance. Homeostasis is maintained in the body, and even a minor change could trigger a compensatory mechanism, in the hopes of keeping everything stable.

4 Sep 2019

MSD collaborates with Francis Crick to find causes of motor neurone disease

Scientists at global biopharmaceutical company MSD and the Francis Crick Institute have started a unique new collaboration to understand the causes of Motor Neurone Disease and identify potential targets for future treatments, co-funded by MSD and the UK Medical Research Council.

21 Aug 2019

Neurodegeneration News and Research

Further Reading

Quanterix announces recipients of annual Accelerator Grant Program

Multiple sclerosis genomic map implicates immune cells in disease susceptibility

Researchers develop superior method to track Alzheimer’s pathology in single neuronal cells

Chan Zuckerberg Initiative supports a patient-led movement to cure ALS

Promising new target regulating mitochondria during stress identified

Quanterix Serum Nf-L assay powers key trial and study results presented at ECTRIMS 2019

Researchers identify changes in retinal layers of patients with mild Alzheimer's disease

Genetic engineering could open possibilities for patients with Parkinson’s disease

Lilly launches new report highlighting challenges and opportunities of health care revolution

Apathy can be used as biomarker of Huntington's disease progression

Scientists visualize protein tangles linked with dementia in patients’ brains after single head injury

Simple urine analysis can be used to quickly identify brain trauma and expedite treatment

New insight and target for Alzheimer’s disease

MSD collaborates with Francis Crick to find causes of motor neurone disease

Northwestern scientists receive $3.1 million grant to investigate drug therapies for ALS

Alzheimer's disease attacks brain regions responsible for wakefulness

Psychiatric symptoms may indicate the beginning of Alzheimer’s disease

Depression symptoms together with AD pathology could trigger changes in memory and thinking

Quanterix corporation releases operating results for second quarter 2019

Alzheimers may be linked to genes that code formation of contacts between neurons

eBook: Neurodegeneration Therapeutics Discovery eBook

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News